The prognosis of the possible foetal and placental complications during delivery by measuring maternal serum levels of pregnancy-specific Beta-1-glycoprotein (SP1)

N. J. Karg, I. F. Csaba, G. Than, A. A. Arany, D. G. Szabó

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The correlation between pathological maternal SP1 serum levels and possible foetal complications during delivery was studied. In 1954, SP1 measurements were made in 823 pregnant women between the 32nd and 40th gestational weeks. On the basis of SP1 serum concentrations groups of patients were formed. The results clearly show that pathological SP1 serum concentrations are frequently associated with intrauterine growth retardation of the foetus, imminent intrauterine asphyxia, and cesarean section indicated by foetal distress. The SP1 placental function-test is recommended as a simple, inexpensive screening method for the detection of placental insufficiency.

Original languageEnglish
Pages (from-to)69-73
Number of pages5
JournalArchives of Gynecology
Volume231
Issue number1
DOIs
Publication statusPublished - Dec 1981

Fingerprint

Pregnancy-Specific beta 1-Glycoproteins
Glycoproteins
Mothers
Serum
Placental Function Tests
Placental Insufficiency
Fetal Distress
Fetal Growth Retardation
Asphyxia
Cesarean Section
Pregnant Women
Fetus

Keywords

  • Foetal complications during delivery
  • Pregnancy-specific beta-1-glycoprotein (SP)

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Medicine(all)

Cite this

The prognosis of the possible foetal and placental complications during delivery by measuring maternal serum levels of pregnancy-specific Beta-1-glycoprotein (SP1). / Karg, N. J.; Csaba, I. F.; Than, G.; Arany, A. A.; Szabó, D. G.

In: Archives of Gynecology, Vol. 231, No. 1, 12.1981, p. 69-73.

Research output: Contribution to journalArticle

@article{733668ee8aa94abdaadcf57b179938c0,
title = "The prognosis of the possible foetal and placental complications during delivery by measuring maternal serum levels of pregnancy-specific Beta-1-glycoprotein (SP1)",
abstract = "The correlation between pathological maternal SP1 serum levels and possible foetal complications during delivery was studied. In 1954, SP1 measurements were made in 823 pregnant women between the 32nd and 40th gestational weeks. On the basis of SP1 serum concentrations groups of patients were formed. The results clearly show that pathological SP1 serum concentrations are frequently associated with intrauterine growth retardation of the foetus, imminent intrauterine asphyxia, and cesarean section indicated by foetal distress. The SP1 placental function-test is recommended as a simple, inexpensive screening method for the detection of placental insufficiency.",
keywords = "Foetal complications during delivery, Pregnancy-specific beta-1-glycoprotein (SP)",
author = "Karg, {N. J.} and Csaba, {I. F.} and G. Than and Arany, {A. A.} and Szab{\'o}, {D. G.}",
year = "1981",
month = "12",
doi = "10.1007/BF02110026",
language = "English",
volume = "231",
pages = "69--73",
journal = "Archiv fur Gynakologie",
issn = "0932-0067",
publisher = "J.F. Bergmann",
number = "1",

}

TY - JOUR

T1 - The prognosis of the possible foetal and placental complications during delivery by measuring maternal serum levels of pregnancy-specific Beta-1-glycoprotein (SP1)

AU - Karg, N. J.

AU - Csaba, I. F.

AU - Than, G.

AU - Arany, A. A.

AU - Szabó, D. G.

PY - 1981/12

Y1 - 1981/12

N2 - The correlation between pathological maternal SP1 serum levels and possible foetal complications during delivery was studied. In 1954, SP1 measurements were made in 823 pregnant women between the 32nd and 40th gestational weeks. On the basis of SP1 serum concentrations groups of patients were formed. The results clearly show that pathological SP1 serum concentrations are frequently associated with intrauterine growth retardation of the foetus, imminent intrauterine asphyxia, and cesarean section indicated by foetal distress. The SP1 placental function-test is recommended as a simple, inexpensive screening method for the detection of placental insufficiency.

AB - The correlation between pathological maternal SP1 serum levels and possible foetal complications during delivery was studied. In 1954, SP1 measurements were made in 823 pregnant women between the 32nd and 40th gestational weeks. On the basis of SP1 serum concentrations groups of patients were formed. The results clearly show that pathological SP1 serum concentrations are frequently associated with intrauterine growth retardation of the foetus, imminent intrauterine asphyxia, and cesarean section indicated by foetal distress. The SP1 placental function-test is recommended as a simple, inexpensive screening method for the detection of placental insufficiency.

KW - Foetal complications during delivery

KW - Pregnancy-specific beta-1-glycoprotein (SP)

UR - http://www.scopus.com/inward/record.url?scp=0019833681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019833681&partnerID=8YFLogxK

U2 - 10.1007/BF02110026

DO - 10.1007/BF02110026

M3 - Article

C2 - 6977342

AN - SCOPUS:0019833681

VL - 231

SP - 69

EP - 73

JO - Archiv fur Gynakologie

JF - Archiv fur Gynakologie

SN - 0932-0067

IS - 1

ER -